However, as shown previously in the studies with breast cancer, ovarian cancer, prostate cancer and other cancer cell lines, the combination of APO2L/TRAIL with Smac mimetics was effective only in some, but not all HCC cells [17], [28]–[30]. This evidence concerns the gene TNFSF10 and prostate carcinoma.